NSAIDs Modulate Clonal Evolution in Barrett's Esophagus

Cancer is considered an outcome of decades-long clonal evolution fueled by acquisition of somatic genomic abnormalities (SGAs). Non-steroidal anti-inflammatory drugs (NSAIDs) have been shown to reduce cancer risk, including risk of progression from Barrett's esophagus (BE) to esophageal adenoca...

Full description

Saved in:
Bibliographic Details
Main Authors: Kostadinov, Rumen L., Kuhner, Mary K., Li, Xiaohong, Sanchez, Carissa A., Galipeau, Patricia C., Paulson, Thomas G., Sather, Cassandra L., Srivastava, Amitabh, Odze, Robert D., Blount, Patricia L., Vaughan, Thomas L., Reid, Brian J., Maley, Carlo C.
Format: Artigo
Language:Inglês
Published: Public Library of Science 2013
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3681672/
https://ncbi.nlm.nih.gov/pubmed/23785299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pgen.1003553
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items